Good morning, trader! We’re gearing up for one final day of trading this week with a breakdown of the biggest pre-market stock gainers for Friday!
But hold up just a minute. Let’s review what the market was up to yesterday. Brenden has us covered with an overview of Friday’s biggest stock stories at this link.
Now that you’re up to speed, let’s talk about those pre-market stock movers for today!
Pre-Market Stock Movers: 10 Top Gainers
$Socket Mobile, Inc.(SCKT.US)$ stock is rocketing more than 81% higher with the release of its earnings report for the second quarter of 2021.
$ALZAMEND NEURO INC(ALZN.US)$ shares are surging over 72% higher with the return of positive results from an Alzheimer’s clinical trial.
$Veoneer Inc(VNE.US)$ stock is soaring more than 55% this morning on news that $Magna International Inc(MGA.US)$ intends to acquire it.
$Acorda Therapeutics Inc(ACOR.US)$ shares are gaining over 54% after announcing plans to commercialize INBRIJA in Spain.
$NRX PHARMACEUTICALS INC(NRXP.US)$ stock is rising more than 37% higher, continuing movement yesterday from its treatment announcement.
$Xenetic Biosciences Inc(XBIO.US)$ shares are increasing over 23% on news of exclusive license agreement partner Takeda Pharmaceuticals investing $126 million to expand its manufacturing operations.
$Snap Inc(SNAP.US)$ stock is gaining more than 17% this morning after releasing its most recent earnings report.
$Forward Pharma A/S(FWP.US)$ shares are heading over 10% higher as retail traders on social media discuss its potential this morning.
$Cyclerion Therapeutics Inc(CYCN.US)$ stock is jumping more than 10% after announcing plans to present data from a clinical trial to treat Alzheimer’s at the Association International Conference 2021.
$American Resources Corp(AREC.US)$ shares are up over 10% in pre-market trading today.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.